156 related articles for article (PubMed ID: 36717804)
1. Comparative transcription profiling of mRNA and lncRNA in pulmonary arterial hypertension after C75 treatment.
Hou C; Xie L; Wang T; Zheng J; Zhao Y; Qiu Q; Yang Y; Xiao T
BMC Pulm Med; 2023 Jan; 23(1):46. PubMed ID: 36717804
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline.
Sun Z; Liu Y; Yu F; Xu Y; Yanli L; Liu N
Biomed Pharmacother; 2019 Jul; 115():108933. PubMed ID: 31060005
[TBL] [Abstract][Full Text] [Related]
3. Identification of
Gong Q; Hu Z; Jin Q; Yan Y; Liu Y; He J; Zhuang L; Wang H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555200
[TBL] [Abstract][Full Text] [Related]
4. Identification of a potentially novel LncRNA-miRNA-mRNA competing endogenous RNA network in pulmonary arterial hypertension via integrated bioinformatic analysis.
Liu J; Sun Y; Zhu B; Lin Y; Lin K; Sun Y; Yao Z; Yuan L
Life Sci; 2021 Jul; 277():119455. PubMed ID: 33831428
[TBL] [Abstract][Full Text] [Related]
5. lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease.
Yang Q; Fan W; Lai B; Liao B; Deng M
PLoS One; 2023; 18(3):e0281061. PubMed ID: 36893166
[TBL] [Abstract][Full Text] [Related]
6. Analyses of long non-coding RNA and mRNA profiles in right ventricle myocardium of acute right heart failure in pulmonary arterial hypertension rats.
Cao Y; Yang Y; Wang L; Li L; Zhang J; Gao X; Dai S; Zhang Y; Guo Q; Peng YG; Wang E
Biomed Pharmacother; 2018 Oct; 106():1108-1115. PubMed ID: 30119177
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel biomarkers involved in pulmonary arterial hypertension based on multiple-microarray analysis.
Ma Y; Chen SS; Feng YY; Wang HL
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32886110
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
9. Profiling and Molecular Mechanism Analysis of Long Non-Coding RNAs and mRNAs in Pulmonary Arterial Hypertension Rat Models.
Hou S; Chen D; Liu J; Chen S; Zhang X; Zhang Y; Li M; Pan W; Zhou D; Guan L; Ge J
Front Pharmacol; 2021; 12():709816. PubMed ID: 34267668
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT
Su H; Xu X; Yan C; Shi Y; Hu Y; Dong L; Ying S; Ying K; Zhang R
Respir Res; 2018 Dec; 19(1):254. PubMed ID: 30547791
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells.
Liu J; Yao Y; Huang J; Sun H; Pu Y; Tian M; Zheng M; He H; Li Z
BMC Genomics; 2022 Jun; 23(1):425. PubMed ID: 35672672
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
Wołowiec Ł; Mędlewska M; Osiak J; Wołowiec A; Grześk E; Jaśniak A; Grześk G
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298685
[TBL] [Abstract][Full Text] [Related]
14. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
Aliotta JM; Pereira M; Amaral A; Sorokina A; Igbinoba Z; Hasslinger A; El-Bizri R; Rounds SI; Quesenberry PJ; Klinger JR
Cardiovasc Res; 2013 Dec; 100(3):354-62. PubMed ID: 23867631
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory.
Jiang Y; Hei B; Hao W; Lin S; Wang Y; Liu X; Meng X; Guan Z
Heart Lung; 2022; 55():16-23. PubMed ID: 35436654
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension.
Zheng H; Hua J; Li H; He W; Chen X; Ji Y; Li Q
Front Genet; 2022; 13():974740. PubMed ID: 36171892
[No Abstract] [Full Text] [Related]
17. Transcriptome profiling and co-expression network analysis of lncRNAs and mRNAs in colorectal cancer by RNA sequencing.
Li M; Guo D; Chen X; Lu X; Huang X; Wu Y
BMC Cancer; 2022 Jul; 22(1):780. PubMed ID: 35842644
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis identifies Toll-like and Nod-like pathways and necroptosis in pulmonary arterial hypertension.
Xiao G; Zhuang W; Wang T; Lian G; Luo L; Ye C; Wang H; Xie L
J Cell Mol Med; 2020 Oct; 24(19):11409-11421. PubMed ID: 32860486
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
[TBL] [Abstract][Full Text] [Related]
20. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
